Medical devices, healthcare technology and the business of care
510(k) clearance · K263313

Red Light Therapy Hair Growth Cap (RB-009, RB-011, RB-012, RB-088, RB-089, RB-092)

Shenzhen Rainbow Technology Co., Ltd. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK263313

What did the FDA decide?

The FDA record lists K263313 as a traditional 510(k) for Shenzhen Rainbow Technology Co., Ltd., covering a Red Light Therapy Hair Growth Cap under model designations RB-009, RB-011, RB-012, RB-088, RB-089 and RB-092. The decision recorded is SESE with a decision date of 2026-10-28, and the specialty field is Physical Medicine with product code OAP. Under the 510(k) pathway, SESE denotes clearance rather than PMA approval.

The record does not describe the device's components, light source specifications, indications for use, or any comparison to a predicate device, and no summary statement text is available in the public information. The relationship between the six model designations is also unstated, so whether they represent variants of one device or separate configurations cannot be determined from this record. No clinical, efficacy or labeling conclusions follow from the clearance entry alone.

The listed document is a premarket notification listing file rather than the individual K263313 summary, so the substantive review basis remains unknown. Readers should consult the matching FDA document for the cleared indications, technological characteristics and any performance data before drawing inferences about the device.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Physical Medicine
Decision date
Oct 28, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263313
Regulatory pathway
510(k) premarket notification
Product code
OAP
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Laser, Comb, Hair.

Product code
OAP
FDA device class
2

FDA decision timeline

  1. K263313 received

    Application receipt date recorded by FDA.

  2. K263313 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OAP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shenzhen Rainbow Technology Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shenzhen

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records